CTAGE5

From Wikipedia, the free encyclopedia


CTAGE family, member 5
Identifiers
Symbol(s) CTAGE5; CTAGE-5A; MEA6; MGEA; MGEA11; MGEA6; cTAGE-5B; cTAGE-5C; cTAGE-5D
External IDs OMIM: 602132 MGI1346056 HomoloGene4336
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 4253 217615
Ensembl ENSG00000150527 ENSMUSG00000021000
Uniprot O15320 Q8R311
Refseq NM_005930 (mRNA)
NP_005921 (protein)
NM_146034 (mRNA)
NP_666146 (protein)
Location Chr 14: 38.8 - 38.93 Mb Chr 12: 60.05 - 60.11 Mb
Pubmed search [1] [2]

CTAGE family, member 5, also known as CTAGE5, is a human gene.[1]


[edit] References

[edit] Further reading

  • Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791–806. PMID 8889548. 
  • Heckel D, Brass N, Fischer U, et al. (1997). "cDNA cloning and chromosomal mapping of a predicted coiled-coil proline-rich protein immunogenic in meningioma patients.". Hum. Mol. Genet. 6 (12): 2031–41. PMID 9356211. 
  • Eichmuller S, Usener D, Dummer R, et al. (2001). "Serological detection of cutaneous T-cell lymphoma-associated antigens.". Proc. Natl. Acad. Sci. U.S.A. 98 (2): 629–34. doi:10.1073/pnas.021386498. PMID 11149944. 
  • Comtesse N, Reus K, Meese E (2001). "The MGEA6 multigene family has an active locus on 14q and at least nine pseudogenes on different chromosomes.". Genomics 75 (1-3): 43–8. doi:10.1006/geno.2001.6576. PMID 11472066. 
  • Comtesse N, Niedermayer I, Glass B, et al. (2002). "MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.". Oncogene 21 (2): 239–47. doi:10.1038/sj.onc.1205005. PMID 11803467. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Usener D, Schadendorf D, Koch J, et al. (2003). "cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.". J. Invest. Dermatol. 121 (1): 198–206. doi:10.1046/j.1523-1747.2003.12318.x. PMID 12839582. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMID 16344560. 
  • Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.". Cell 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.